The Journal of Immunology, Vol 138, Issue 2 532-538, Copyright © 1987 by American Association of Immunologists

ARTICLES

Synthesis and release of leukotriene C4 by human eosinophils

WF Owen Jr, RJ Soberman, T Yoshimoto, AL Sheffer, RA Lewis and KF Austen

When human peripheral blood eosinophils isolated to 92.5% +/- 6.9 purity were stimulated with either the calcium ionophore A23187 or N- formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP), immunoreactive leukotriene C4 (LTC4) was initially localized intracellularly and was subsequently released to the external medium in kinetically distinguishable steps. Eosinophils were stimulated with 2.5 microM A23187 in the presence of 20 mM L-serine, a hypochlorous acid scavenger that prevents the oxidative metabolism of sulfidopeptide leukotrienes. Total production of immunoreactive LTC4, the sum of intra- and extracellular LTC4, was complete within 5 to 10 min. At 5, 10, and 30 min, 65.9% +/- 15.2, 42.3% +/- 24.3, and 5.5% +/- 3.9, respectively, of the total amount of LTC4 measured remained intracellular as detected after the media and cells were separated and the latter was extracted with methanol. The time course for the intracellular synthesis and extracellular release of immunoreactive LTC4 from eosinophils pretreated with 5 micrograms/ml cytochalasin B and stimulated with 0.5 microM FMLP was like that obtained with ionophore, although the total LTC4 production was only approximately 10%. The identity of the intracellular LTC4 was confirmed by elution with reverse-phase high pressure liquid chromatography followed by scanning UV spectroscopy, radioimmunoassay, and bioassay. Eosinophils that were stimulated with A23187 in the absence of L-serine metabolized newly synthesized LTC4 to 6-trans-LTB4 diastereoisomers and subclass-specific diastereoisomeric sulfoxides that were identified only in the extracellular medium. Thus the response of purified eosinophils to two different stimuli demonstrates a transient intracellular accumulation of biologically active LTC4, the distinct extracellular release, and the apparent limitation of oxidative metabolism to the extracellular location.

This article has been cited by other articles:

				A. Mainnemare, B. Megarbane, A. Soueidan, A. Daniel, and I.L.C. Chapple Hypochlorous Acid and Taurine-N-Monochloramine in Periodontal Diseases Journal of Dental Research, November 1, 2004; 83(11): 823 - 831. [Abstract] [Full Text] [PDF]

				N. Tedla, C. Bandeira-Melo, P. Tassinari, D. E. Sloane, M. Samplaski, D. Cosman, L. Borges, P. F. Weller, and J. P. Arm Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7 PNAS, February 4, 2003; 100(3): 1174 - 1179. [Abstract] [Full Text] [PDF]

				S. H. P. Oliveira, S. Lira, C. Martinez-A, M. Wiekowski, L. Sullivan, and N. W. Lukacs Increased responsiveness of murine eosinophils to MIP-1{beta} (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8 J. Leukoc. Biol., June 1, 2002; 71(6): 1019 - 1025. [Abstract] [Full Text] [PDF]

				A. Sano, X. Zhu, H. Sano, N. M. Munoz, E. Boetticher, and A. R. Leff Regulation of eosinophil function by phosphatidylinositol-specific PLC and cytosolic PLA2 Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L844 - L851. [Abstract] [Full Text] [PDF]

				T. Urasaki, J. Takasaki, T. Nagasawa, and H. Ninomiya Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway J. Leukoc. Biol., January 1, 2001; 69(1): 105 - 112. [Abstract] [Full Text]

				M. Tomaki, L.-L. Zhao, J. Lundahl, M. Sjostrand, M. Jordana, A. Linden, P. O'Byrne, and J. Lotvall Eosinophilopoiesis in A Murine Model of Allergic Airway Eosinophilia: Involvement of Bone Marrow IL-5 and IL-5 Receptor {alpha} J. Immunol., October 1, 2000; 165(7): 4040 - 4050. [Abstract] [Full Text] [PDF]

				M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]

				M. Nagata, J. B. Sedgwick, H. Kita, and W. W. Busse Granulocyte Macrophage Colony-stimulating Factor Augments ICAM-1 and VCAM-1 Activation of Eosinophil Function Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 158 - 166. [Abstract] [Full Text]

				B. M. Taylor, K. P. Kolbasa, J. E. Chin, I. M. Richards, W. E. Fleming, R. L. Griffin, S. F. Fidler, and F. F. Sun Roles of Adhesion Molecules ICAM-1 and alpha 4 Integrin in Antigen-induced Changes in Microvascular Permeability Associated with Lung Inflammation in Sensitized Brown Norway Rats Am. J. Respir. Cell Mol. Biol., December 1, 1997; 17(6): 757 - 766. [Abstract] [Full Text]

				A. R. SOUSA, B. E. A. LAMS, R. PFISTER, P. E. CHRISTIE, M. SCHMITZ, and T. H. LEE Expression of Interleukin-5 and Granulocyte-Macrophage Colony-stimulating Factor in Aspirin-sensitive and Non-Aspirin-sensitive Asthmatic Airways Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1384 - 1389. [Abstract] [Full Text]

				Q. Yuan, K. F. Austen, D. S. Friend, M. Heidtman, and J. A. Boyce Human Peripheral Blood Eosinophils Express a Functional c-kit Receptor for Stem Cell Factor that Stimulates Very Late Antigen 4 (VLA-4)-mediated Cell Adhesion to Fibronectin and Vascular Cell Adhesion Molecule 1 (VCAM-1) J. Exp. Med., July 21, 1997; 186(2): 313 - 323. [Abstract] [Full Text] [PDF]

				E. Israel, P. Rubin, J. P. Kemp, J. Grossman, W. Pierson, S. C. Siegel, D. Tinkelman, J. J. Murray, W. Busse, A. T. Segal, et al. The Effect of Inhibition of 5-Lipoxygenase by Zileuton in Mild-to-Moderate Asthma Ann Intern Med, December 1, 1993; 119(11): 1059 - 1066. [Abstract] [Full Text]

				M. Rothenberg, W. Owen Jr, D. Silberstein, R. Soberman, K. Austen, and R. Stevens Eosinophils cocultured with endothelial cells have increased survival and functional properties Science, August 7, 1987; 237(4815): 645 - 647. [Abstract] [PDF]